Ligand Pharmaceuticals' Q3 2024 earnings report beat on the top and bottom lines, reinforcing my confidence. Read what makes ...

The world of pharmacenutical stocks has a lot to offer investors. With their resilience in the face of economic issues and ...

Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might ...

Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might ...

The novel therapy, delivered via implantable, pill-sized device, improved RA signs and symptoms in patients receiving daily ...

Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...

A study using a Korean database found that COVID-19 infection raised long-term risks for various autoimmune and ...

Analyzing Amgen's stock drop, management's response, and potential for growth in GLP-1 candidate MariTide in a volatile ...

Howard Chang will take over as chief scientific officer and senior VP of research as the biotech searches for more ways to ...

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...

With the recent spike in implied volatility, an iron condor on Amgen can use short strikes with a wide profit range.

Despite the very positive setup facing Amgen as a result of its ongoing and future investments in developing new ...